SCHEMBL4078239

SCHEMBL4078239

CC(c1ccccc1)c1ccc(OC(=O)CCl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
ESR1 P03372 1/20 0.45
HIF1A Q16665 1/20 0.45
ELANE P08246 2/20 0.44
FFAR1 O14842 2/20 0.43
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
NPY5R Q15761 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL137047 0.80 CYP19A1 (0.52) ALDH1A1HIF1AELANELMNAATM
SCHEMBL28927408 0.80 ELANE (0.59) ALDH1A1ESR1HIF1AELANELMNA
SCHEMBL11467265 0.79 CYP19A1 (0.50) ALDH1A1HIF1AELANELMNAATM
SCHEMBL4095285 0.78 KMT2A (0.52) ALDH1A1ESR1HIF1AELANELMNA
SCHEMBL10499600 0.78 RNF4 (0.57) ALDH1A1ELANEFFAR1SMN1; SMN2HTT
SCHEMBL30440320 0.77 ATM (0.41) ALDH1A1ELANELMNASMN1; SMN2ATM
SCHEMBL17386333 0.75 ELANE (0.49) ALDH1A1ELANEFFAR1LMNAATM
SCHEMBL9794842 0.75 ALDH1A1 (0.50) ALDH1A1ESR1HIF1AELANEFFAR1
SCHEMBL4078245 0.75 KMT2A (0.54) ELANEFFAR1SMN1; SMN2ATMKMT2A
SCHEMBL1507705 0.74 TDP1 (0.47) ALDH1A1ESR1HIF1AELANELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1845970-A4 TUMOR NECROSIS FACTOR INHIBITORS CEPTION THERAPEUTICS INC (US) 2009-02-18 EP disclosed
EP-1845970-A2 TUMOR NECROSIS FACTOR INHIBITORS Ception Therapeutics, Inc. (US) 2007-10-24 EP disclosed
WO-2006083970-A2 TUMOR NECROSIS FACTOR INHIBITORS CEPTION THERAPEUTICS, INC. (US) 2006-08-10 WO disclosed